Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03662659
Title	An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Bristol-Myers Squibb
Indications	stomach cancer gastroesophageal junction adenocarcinoma
Therapies	Nivolumab + Relatlimab + Tegafur-gimeracil-oteracil Potassium Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Relatlimab Nivolumab + Tegafur-gimeracil-oteracil Potassium Capecitabine + Nivolumab + Oxaliplatin Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin Capecitabine + Nivolumab + Oxaliplatin + Relatlimab
Age Groups:	adult \| senior
Covered Countries	USA \| POL \| NOR \| ITA \| GBR \| FRA \| ESP \| DEU \| CZE \| CAN \| BEL \| AUT \| AUS \| ARG